Complement-Based Antibiotic Microbeads

Todd Sulchek of Georgia Tech and David White of the Centers for Disease Control in the U.S. will develop and test the ability of a bi-functional microbead to stimulate the innate immune response. On one hemisphere, the microbead will display targeting antibodies that will bind to pathogens, and on the other hemisphere the microbead will feature Fc fragments that activate the complement system and recruit immune cells to destroy the captured pathogen.